• Overview
• Who Should Attend
• Speaking Faculty
• Agenda
• Download Agenda
• Partnering Opportunities
• Sponsorship / Exhibit Opportunities
• Sponsors / Exhibitors
• Partners / Media
• Venue & Hotel Information
• Registration Fees
• Register Here
• Event Blog
• Photo Gallery
• Sign up for Updates

Overview

The drug delivery industry is expected to experience robust growth over the next five to ten years, primarily due to the increasing prevalence of chronic conditions, increase in biologic drug approvals, and growing geriatric population. Often, the most complex part of developing a therapeutic is to design an appropriate delivery system for it. The use of drug delivery technologies will continue to rise, as the industry focuses on more cost-effective, targeted, and patient-centered therapies.

The 9th annual Partnership Opportunities in Drug Delivery (PODD) conference is a business development event covering the latest advances in drug delivery science, while also providing a meeting place to network and form new partnerships. The PODD event features a wide range of innovative drug delivery technologies that could potentially improve the delivery of various types of drugs, including proteins, peptides, oligonucleotides, biologics, and small molecules.

Key Topics for 2019

Reasons to Attend

• Hear from renowned biomedical engineer and entrepreneur, Dr Robert Langer of MIT, as well as other leading key opinion leaders from industry and academia
• Learn about the latest drug delivery technology solutions for both small and large molecule drugs, ranging from oral, transdermal, and transmucosal dosage forms to more patient-friendly delivery devices (more than 45 presentations and 50 exhibitors).
• Network with key decision makers from pharmaceutical, biotechnology, and medical device companies and exploring areas for potential collaboration (more than 8 hours of networking).
• Discover the current drug delivery needs of pharma and biotech companies and determining what they are looking for in terms of external delivery technologies.
• Participate in discussions with colleagues tackling the latest delivery challenges in areas such as gene therapy and biologics-based new therapeutic modalities

The PODD promise:

1. Present a strategic-level program for pharma and biotech scientists and business development professionals, with a thorough overview on formulation needs, the latest drug delivery technologies available along with an update on deals and opportunities to improve therapies and extend the life cycle of a drug.
2. Provide drug delivery and specialty pharmas with a platform to present their technologies.
3. Offer ample networking time and services for one-on-one meetings to establish new business contacts and enhance existing ones.

Sincerely,

Valerie Bowling Executive Director	Meredith Sands Executive Director, Business Development
Michelle McDermott Conference Producer	Meg Gould Senior Conference Planner
Geeta Bachani Business Development Manager	Bre Bugbee Marketing Manager

Testimonials

• "Incredible! Fantastic overview of the industry, recent, partnerships and opportunities for the future. Helpful input on panels, speaker presentations and what's in the pipeline. Great networking opportunities and sharing insights with colleagues. Hard to choose just one area - was all invaluable."

  - Kristin King, Rogers Sciences

• "Overall very satisfied. Best was networking, coming across new technologies that I did not necessarily have on the radar, and the speaker’s program."

  - Gregoire Schwach, Roche

• "Was a great conference and getting better every year!"

  - Rudy Emmelot, IntraTab Labs

• "I have to say PODD was a great opportunity for me. I learned a lot and met great people. Thanks to The Conference Forum."

  - Sina Eetezadi, Roche Pharmaceuticals

• "Congratulations on a very successful conference! It is a very unique conference and I enjoyed it very much."

  - Avinash G. Thombre, PhD, Pfizer Inc

• "I was honestly very much impressed by the conference, the set up with presentations and panels and the high level number of executives from the different stakeholders."

  - Sven Stegemann, PhD, Geriatric Medicine Society

• "This was a great partnering event for us. In addition to our product development services, we have a couple of proprietary technologies that we are promoting. The right group of Directors, Exec Dir, VPs were at the meeting who were all looking for delivery technologies."

  - Chris Rhodes, Drug Delivery Experts